Edmond de Rothschild Holding’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-30,500
Closed -$2K 770
2018
Q3
$2K Hold
30,500
﹤0.01% 733
2018
Q2
$3K Hold
30,500
﹤0.01% 731
2018
Q1
$11K Hold
30,500
﹤0.01% 732
2017
Q4
$40K Hold
30,500
﹤0.01% 656
2017
Q3
$444K Buy
30,500
+4,000
+15% +$545K 0.01% 378
2017
Q2
$366K Buy
26,500
+3,000
+13% +$368K 0.01% 413
2017
Q1
$240K Buy
+23,500
New +$2.81M 0.01% 463

Other funds holding CELG

Edmond de Rothschild Holding's CELG Position: Q4 2019 in Review

Edmond de Rothschild Holding sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 99,360 shares — an estimated $9.87M sold.

Edmond de Rothschild Holding first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $60M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Edmond de Rothschild Holding reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 99,360 Celgene Corp shares in Q4 2019, an estimated $9.87M.
  • Edmond de Rothschild Holding first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • Edmond de Rothschild Holding's Celgene Corp position peaked at $60M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2019, filed 14 Feb 2020.